Label-Free Technologies For Drug Discovery
Matthew Cooper, Lorenz M. Mayr
John Wiley & Sons, Feb 11, 2011 - Medical - 352 pages
Over the past two decades the benefits of label-free biosensor analysis have begun to make an impact in the market, and systems are beginning to be used as mainstream research tools in many drug discovery laboratories.
Label-Free Technologies For Drug Discovery summarises the latest and emerging developments in label-free detection systems, their underlying technology principles and end-user case studies that reveal the power and limitations of label-free in all areas of drug discovery.
Label-free technologies discussed include SPR, NMR, high-throughput mass spectrometry, resonant waveguide plate-based screening, transmitted-light imaging, isothermal titration calorimetry, optical and impedance cell-based assays and other biophysical methods. The technologies are discussed in relation to their use as screening technologies, high-content technologies, hit finding and hit validation strategies, mode of action and ADME/T, access to difficult target classes, cell-based receptor/ligand interactions particularly orphan receptors, and antibody and small molecule affinity and kinetic analysis.
Label-Free Technologies For Drug Discovery is an essential guide to this emerging class of tools for researchers in drug discovery and development, particularly high-throughput screening and compound profiling teams, medicinal chemists, structural biologists, assay developers, ADME/T specialists, and others interested in biomolecular interaction analysis.
What people are saying - Write a review
Design and Implementation of Vertically Emitting
SPR Screening of Chemical Microarrays
The CellKey System A LabelFree CellBased
Dynamic and LabelFree CellBased Assays Using
Incorporating Transmitted Light Modalities into
Nonradioactive Rubidium Efflux Assay
Expanding the Scope of HTMS Methods
Harnessing Optical LabelFree on Microtiter
Use of LabelFree Detection Technologies in
Novartis Evaluation of the ForteBio Octet RED
The PyramidTV Approach to FragmentBased
Characterisation of Antibodies Against
SPRBased Direct Binding Assays in Drug
Kinetic Binding Mechanisms Their Contribution
ITC More Than Just Binding Affinities